Charles PG - Search Results

1

Point-of-care tests for lower respiratory tract infections.

Charles PG, Grayson ML. Charles PG, et al. Med J Aust. 2007 Jul 2;187(1):36-9. doi: 10.5694/j.1326-5377.2007.tb01112.x. Med J Aust. 2007. PMID: 17605701 Review.

2

Management of healthcare workers after occupational exposure to hepatitis C virus.

Charles PG, Angus PW, Sasadeusz JJ, Grayson ML. Charles PG, et al. Med J Aust. 2003 Aug 4;179(3):153-7. doi: 10.5694/j.1326-5377.2003.tb05475.x. Med J Aust. 2003. PMID: 12885285

3

The dearth of new antibiotic development: why we should be worried and what we can do about it.

Charles PG, Grayson ML. Charles PG, et al. Med J Aust. 2004 Nov 15;181(10):549-53. doi: 10.5694/j.1326-5377.2004.tb06444.x. Med J Aust. 2004. PMID: 15540967

4

It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia.

Charles PG, Cheng AC, Grayson ML. Charles PG, et al. Intern Med J. 2014 Nov;44(11):1148. doi: 10.1111/imj.12571. Intern Med J. 2014. PMID: 25367733 No abstract available.

5

Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective.

Howden BP, Ward PB, Johnson PD, Charles PG, Grayson ML. Howden BP, et al. Among authors: charles pg. Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):100-8. doi: 10.1007/s10096-004-1261-y. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15682283 Review.

6

Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency.

Gordon CL, Johnson PD, Permezel M, Holmes NE, Gutteridge G, McDonald CF, Eisen DP, Stewardson AJ, Edington J, Charles PG, Crinis N, Black MJ, Torresi J, Grayson ML. Gordon CL, et al. Among authors: charles pg. Clin Infect Dis. 2010 Mar 1;50(5):672-8. doi: 10.1086/650462. Clin Infect Dis. 2010. PMID: 20121412

7

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML. Charles PG, et al. Clin Infect Dis. 2004 Feb 1;38(3):448-51. doi: 10.1086/381093. Epub 2004 Jan 12. Clin Infect Dis. 2004. PMID: 14727222

8

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.

Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML. Howden BP, et al. Among authors: charles pg. Clin Infect Dis. 2004 Feb 15;38(4):521-8. doi: 10.1086/381202. Epub 2004 Jan 29. Clin Infect Dis. 2004. PMID: 14765345

9

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.

Bishop E, Melvani S, Howden BP, Charles PG, Grayson ML. Bishop E, et al. Among authors: charles pg. Antimicrob Agents Chemother. 2006 Apr;50(4):1599-602. doi: 10.1128/AAC.50.4.1599-1602.2006. Antimicrob Agents Chemother. 2006. PMID: 16569895 Free PMC article.

10

Conundrums in community-acquired pneumonia.

Charles PG, Johnson PD, Grayson ML. Charles PG, et al. Med J Aust. 2006 Aug 7;185(3):131-2. doi: 10.5694/j.1326-5377.2006.tb00496.x. Med J Aust. 2006. PMID: 16893350 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters